Curriculum Vitae Michaela Kunz Mathews, M. D. Assistant Professor, Ophthalmology University of Maryland School of Medicine Contact Information
Yüklə 51,59 Kb.
|
- Bu səhifədəki naviqasiya:
- Post Graduate Education and Training
- Board Certification
- Employment History Academic Appointments
- Explanation of gaps in Education and Employment History
- Scope of Clinical Practice
- Administrative Service Institutional Service
- Local Service
- Graduate Student Teaching
- Resident and Fellow teaching
- Grant Support Completed Grants 9/1/09 - 8/31/2015 (no cost extension) PI: 80% “
- Publications Peer-reviewed journal articles
- Non-peer-reviewed journal articles
- Proffered Communications
|
Curriculum Vitae Michaela Kunz Mathews, M.D. Assistant Professor, Ophthalmology University of Maryland School of Medicine Contact Information: Business Address: 419 W. Redwood Street, Ste 420 Baltimore, MD 21201 10 S Pine St., MSTF 500-C Business Phone: 667-214-1232 Fax: 410 328 1178 Email: mmath002@umaryland.edu
8/13/1983 – 1/24/1991 Medical School, University of Vienna, Austria 1/24/1991: M.D. - University of Vienna, Austria
4/1/1991 - 9/30/1994 Internship / Family Medicine Residency Krankenanstalt des Göttlichen Heilandes Dornbacher Straße 20-28, 1170 Wien, Austria 10/1/1994 – 5/31/1997 Postdoctoral Fellowship The Wilmer Eye Institute Johns Hopkins University School of Medicine 733 N. Broadway, Baltimore, MD 21287 Mentor: Gerard A Lutty, Ph.D., Professor of Ophthalmology
2005, renewed 2015 (expires 2025) Diplomat, American Board of Ophthalmology Medical Licensures 1991 Active Austria 1998 Inactive New Jersey 2001 Inactive Pennsylvania 2004 Active Maryland
9/29/04 – 7/31/06 Clinical Assistant Professor University of Maryland School of Medicine Dept. of Ophthalmology 8/1/2006 – present Assistant Professor University of Maryland School of Medicine Dept. of Ophthalmology 3/1/2009 - present Adjunct appointment: Assistant Professor University Of Maryland School of Medicine Dept. of Anatomy and Neurobiology Other Employment 10/1995 – 05/1996 Research Assistant Department of Anesthesiology, Johns Hopkins Hospital 600 N. Wolfe St., Baltimore, MD 21287 Supervisor: Quentin Fisher, M.D., Assistant Professor of Anesthesiology
2007 Attending of the year – University of Maryland School of Medicine, Department of Ophthalmology Clinical Activities 2004 - present Clinical practice at University of Maryland Faculty Physicians, Inc. 2004 - present Attending Physician, Baltimore VA Hospital 2004 - 2009 Ophthalmology Consultant, The Joslin Diabetes Center University of Maryland Medical Center 500 patient visits / year 2006 - present Director, Ophthalmology Consult Service University of Maryland Medical Center 2000 patients/year Clinical Expertise Board certified Ophthalmologist, Subspecialty fellowship training in Neuroophthalmology. Expertise in optic neuropathies (congenital, ischemic, compressive, demyelinating, inflammatory, traumatic), ocular motility disorders, disorders of higher visual functions, disorders of ocular innervation, idiopathic intracranial hypertension, systemic diseases, central nervous system disorders, tumors, and other malignancies affecting ocular motility and function,
419 W Redwood St. Baltimore, MD
Owings Mills, MD Waterloo Crossing Columbia, MD Other sites: University of MD Medical Center S Greene St, Baltimore, MD Baltimore, VA Medical Center N Greene St., Baltimore, MD (starting 2017) University of MD Rehabilitation and Orthopedic Institute Kernan Drive, Baltimore, MD Total number of patients/week: 40 Number of referrals received/week: 25 Responsibilities with practice: Director, Neuroophthalmology service Director, Consult Service Physician Compliance Liaison EPIC / Portfolio Physician Champion Portfolio Inpatient Physician Champion Grand Rounds Committee Total time spent in clinical duties: 35 Recent Innovations that have influenced practice: Optical Coherence Tomography: Recent advances in image quality and imaging analysis software allow detailed analysis of optic nerve abnormalities and longitudinal follow-up. Cancer therapy: New innovative treatment strategies, such as proton beam therapy, have significantly increased individual survival rates and lead to more patients presenting with complex neuroophthalmologic complications of their cancer of treatment side-effects.
2010 – 2015 Participating Investigator: A double-blind, placebo-controlled study to evaluate new or worsening lens opacification in subjects with non-metastatic prostate cancer receiving Denosumab for bone loss due to Androgen-deprivation therapy. Protocol 20080560; Sponsor: Amgen, Inc. Time commitment: 2 % 2015 – present Participating Investigator: A Phase 2/3, Double-masked, Placebo-controlled Study with Open-label Extension to Evaluate the Safety and Efficacy of MEDI-551 in Adult Subjects with Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders Sponsor: Medimmune , Inc. Time commitment: 2% 2015 – present Participating Investigator: Long term, prospective, multinational, parallel-cohort study monitoring safety in patients with MS newly started on fingolimod once daily or treated with another approved disease-modifying therapy. (CFTY720D2403) Sponsor: Medimmune, Inc. Time commitment: 2%
2006 - present Physician Compliance Liaison, University Eye Care 2006 - present Director, Ophthalmology Consult Service 2010 - present Portfolio Ambulatory Provider Workgroup / User Group Representative 2012 - present School of Medicine Council (alternative) 2013 Ophthalmology Clinical Competency Committee 2013 Ophthalmology Annual Program Review Committee 2014 - present EPIC / Portfolio Physician Champion Committee 2014 - present Portfolio UMMS Provider Champion Committee
Ad Hoc Reviewer: Cephalalgia, European Journal of Neurology, European Journal of Ophthalmology, Graefe’s Archive for Clinical and Experimental Ophthalmology, Current Eye Research, PLOS online, Eye. Local Service Parent Volunteer: Cromwell Valley Elementary School; Girl Scouts of America, Troop 2455; Boy Scouts of America, Troop 742 Teaching Service Undergraduate Student Teaching 2014 Mentor, Summer Research Program, 1 student - 10 contact hours/year 2017 Thesis Discussant, University of Maryland Gemstone Honors Research Program
2009 - present ICME 520 Introduction to Clinical Medicine Lecturer University of Maryland School of Medicine Classroom lecture 160 student hours/year 2006 - present GSUR 531,Ophthalmology Elective Clinical instructor University of Maryland, School of Medicine Practice - based individual instruction. 500 student hours / year 2010 - 2013 NPSC 518A Gross Anatomy dissection course Guest Instructor University of Maryland Dental School Lab
200 student hours/year 2012 - 2013 HGEN 731: Ophthalmic Genetics Lecturer University of Maryland School of Medicine Masters in Genetic counseling program. 25 student hours/year 2013 - 2015 OPTH 589 Ophthalmology Research Mentor 80 student hours / year 2014 - present MSPR 514 Medical Neuroscience Lecturer University of Maryland School of Medicine 350 student hours/year 2015 - present OPTH 541 Ophthalmology Elective Clinical instructor 500 Student hours/year 2016 - present NEUR 530 Neurology Clerkship Lecturer Neuroophthalmology lecture for MS3 students 100 Student hours/year 2016 - present FAPH 530 Family Medicine Clerkship Lecturer Neuroophthalmology lecture for MS3 students 100 Student hours/year Resident and Fellow teaching 2004 - present Clinical Faculty, Department of Ophthalmology University of Maryland, School of Medicine 12 residents Practice - based teaching: Neuroophthalmology, General Ophthalmology, Ophthalmology consults and emergencies; Major and minor surgical procedures. >250 contact hours/year 2004 - present Neuroophthalmology lecture series for Ophthalmology residents 150 contact hours/year 2006 - present Director and attending physician, Ophthalmology Consult Service Inpatient, Emergency, Shock-Trauma consult rounds Minor procedures, Major emergency procedures 1 resident, 2 students 100 contact hours / year 2014 - present Neuroophthalmology lecture for Neurology residents ~20 residents 40 contact hours/year 2016 - present Neuroophthalmology lecture for Medicine residents ~25 residents 25 contact hours/year
National Eye Institute, 1KO8EY016357 - 01A2 Annual Direct Cost: $174,693 Total Direct Cost: $831,115 7/1/1996 – 6/30/1997 PI: 100% “The role of Adenosine in canine retinal microvascular endothelial cell migration and tube formation.” Knights Templar Eye Foundation Annual direct cost: $70,000 Publications Peer-reviewed journal articles 1. MK Mathews, C Merges, DS McLeod, GA Lutty Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 1997 Dec; 38 (13): 2729-41. 2. GA Lutty#, MK Mathews, C Merges, DS McLeod Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation. Curr. Eye Res. 1998 Jun; 17(6): 594-607. 3. J Cao, MK Mathews, DS McLeod, C Merges, LM Hjelmeland, GA Lutty Angiogenic factors in human proliferative sickle cell retinopathy. Br. J. Ophthalmol. 1999 Jul; 83(7): 838-46. 4. M Kunz-Mathews, DS McLeod, C Merges, J Cao, GA Lutty Neutrophils and leucocyte adhesion molecules in sickle cell retinopathy. Br. J. Ophthalmol. 2002; 86:684-690. 5. R. Behbehani, MK Mathews, RC Sergott, PJ Savino Non-arteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure. Am. J. Ophthalmol 2005; 139:518-521 6. MK Mathews, L Frohman, HJ Lee, RC Sergott, PJ Savino Spinal fluid leak after chiropractic manipulation of the cervical spine. Arch Ophthalmol 2006; 124(2): 283 7. RR Sayegh, KA Madsen, JD Adler, MA Johnson, MK Mathews: Diffuse retinal injury from a non-penetrating TASER dart. Documenta Ophthalmologica 2011; 123 (2): 135-139 8. RR Sayegh, KA Madsen, JD Adler, MA Johnson, MK Mathews: Response to TASER electronic control devices and eye injuries. Documenta Ophthalmologica 2012 Apr;124(2):161-2 9. N Bhatt, R Morales, M Mathews: MRI Findings in Bilateral Post-operative Posterior Ischemic Optic Neuropathy. Open Journal of Ophthalmology. 2013, 3, 51-53. http://dx.doi.org/10.4236/ojoph.2013.33013 10. Mathews M, Albukh T, Duncan K. Early ocular lipid deposition in a mouse model of hyperlipidemia and atherosclerosis. Invest Ophthalmol Vis Sci. 2013;54(15):4104-4104. 11. MK Mathews, Y Guo, P Langenberg, SL Bernstein. Ciliary neurotrophic factor (CNTF) - mediated ganglion cell survival in a rodent model of non-arteritic anterior ischaemic optic neuropathy (NAION). Br J Ophthalmol., 2015;99:133-137 doi:10.1136/bjophthalmol-2014-305969 12. E Couser, SL Bernstein, MK Mathews. Effect of Alzheimer's Disease on Melanopsin Expression in the Lateral Geniculate Nucleus. Invest. Ophthalmol. Vis. Sci. 2015;56(7):5561. 13. MA Malouf, R Levin, MK Mathews. Leber’s Hereditary Optic Neuropathy - Not just a young men’s disease. J Am Geriatr Soc 2016; 64(1): 232. AID JGS13899. Non-peer-reviewed journal articles 1. MK Mathews, RC Sergott, PJ Savino Pseudotumor cerebri. Curr Opin Ophthalmol 2003; 14(6): 364-370. Reprinted in Contemporary Ophthalmology 2004; 25(3). Review 2. MK Mathews Nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol. 2005; 16(6):341-5. Review Abstracts and/or Proceedings 1. M Kunz, CA Merges, DS McLeod, GA Lutty Effects of adenosine on canine retinal capillary endothelial cell migration and vascular cord formation. IOVS 1995; 36(4): S894. 2. M Kunz, C Merges, DS McLeod, GA Lutty Vascular endothelial growth factor / vascular permeability factor (VEGF) in diabetic retinopathy. IOVS 1996; 37(3): S119. 3. MK Mathews, J Cao, C Merges, DS McLeod, GA Lutty Adhesion molecules, neutrophils and imbalance in the fibrinolytic system in sickle cell retinopathy. IOVS 1997; 38(4): S1117.
1. “Diabetic Eye disease “ The Joslin Diabetes Center; University of Maryland Medical Center. Nov.2006. 2.”What’s New in Diabetic Retinopathy” The Joslin Diabetes Center, University of Maryland Medical Center. Nov. 2007 3. “Nonarteritic Ischemic Optic Neuropathy as a Predictor of Cardiovascular Disease” Austrian Scientists in North America (ASCINA) National Institutes of Health, Bethesda, MD. May, 2009 4. “What's New in Diabetic Retinopathy” The Joslin Diabetes Center, University of Maryland Medical Center. Nov. 2010
1. March 22, 2001: 27th annual meeting of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS), 2. March 30, 2001: The Wills Eye Hospital 54th Annual Conference Title: Management of Descemet’s rupture from birth trauma with a rigid gas permeable contact lens. Authors: MK Mathews, BM Schnall, EJ Cohen 3. May 5, 2002: Association for Research in Vision and Ophthalmology (ARVO), Title: The Super Pinhole test for potential acuity in eyes with cataract. Authors: MK Mathews, R Rothermel, SM Soll, DB Soll 4. March 14, 2003: The Wills Eye Hospital 55th Annual Conference
5. Feb 12, 2007: North American NeuroOphthalmology Society (NANOS), Title: Iatrogenic Horner syndrome diagnosed with 0.5% Apraclonidine. Authors: A Guerami, MK Mathews 6. May 8, 2007: Association for Research in Vision and Ophthalmology (ARVO) Title: A new transgenic mouse model of neuroprotection in ischemic optic neuropathy. Authors: MK Mathews, Y Guo, SL Bernstein 7. Feb. 29, 2008: Richard D. Richards Lecture Symposium University of Maryland School of Medicine Title: Neuroprotection in ischemic optic neuropathy. Authors: A Hunter, MK Mathews, SL Bernstein 8. Feb. 29, 2009: NANOS 2009 Annual Meeting, Poster # 51 Title: Severe Vision Loss in Tumors of the Paranasal Sinuses. Authors: SK Mistr, JC Sailey, MK Mathews 9. May 4, 2009: ARVO Annual Meeting, Poster # 1447 Neuroprotective Effect of Ciliary Neurotrophic Factor (CNTF) in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy. Authors: MK Mathews, SL Bernstein 10. May 6, 2009: ARVO Annual Meeting, Poster # 4936 Lipoprotein A and C-Reactive Protein in Age-Related Macular Degeneration. Authors: IA Bhutto, T Baba, C Merges, DS McLeod, MK Mathews, GA Lutty 11. March 9, 2010: NANOS 2010 Annual Meeting, Poster # 2 Title: A Case of Unilateral Optic Neuritis due to Sinus Polyposis. Authors: LK Law, MK Mathews 12. May 4, 2011: ARVO Annual Meeting, Poster # 4079 Title: Choroidal Changes in the LDL-Receptor-Deficient Mouse Model of Hyperlipidemia and Atherosclerosis. Author: MK Mathews 13. February 14, 2012: NANOS 2012 Annual Meeting Poster Title: New Onset Leber’s Hereditary Optic Neuropathy in a 79 year-old Male Authors: M Malouf, R Levin, RK Shin, MA Johnson, RA Liss, MK Mathews 14. February 14, 2012: NANOS 2012 Annual Meeting Poster Title: A Case of Sudden, Reversible Vision Loss Secondary to Allergic Fungal Sinusitis Authors: EB Moses, MK Mathews 15. February 14, 2012: NANOS 2012 Annual Meeting Poster Title: Intraorbital Optic Nerve Enhancement on Magnetic Resonance Imaging in Postoperative Ischemic Optic Neuropathy Authors: NP Bhatt, MK Mathews 16. May 29,2012: Richard D. Richards Lecture Symposium, University of Maryland School of Medicine Title: Ultrastructural Changes in a Murine Model of Hyperlipidemia and Retinal Degeneration. Author: MK Mathews 17. May 8, 2013: 2013 ARVO Annual Meeting presentation number 4104 Title: Early ocular lipid deposition in a mouse model of hyperlipidemia and atherosclerosis Authors: MK Mathews, T Albukh 18. March 4, 2014: NANOS 2012 Annual Meeting Poster #78 Title: A case of traumatic CSF blepharocele presenting as fluctuating eyelid edema. Authors: LR Katzman, MK Mathews 19. June 21, 2014: Richard D Richards Symposium. University of Maryland School of Medicine, Dept. of Ophthalmology Title: Chorioretinal changes in hyperlipidemia Author: MK Mathews 20. May 7, 2015: ARVO Annual meeting Abstract # 5561 Title: Effect of Alzheimer's Disease on Melanopsin Expression in the Lateral Geniculate Nucleus. Authors: E Couser , SL Bernstein , MK Mathews 21. June 19, 2015: Richard D Richards Symposium. University of Maryland School of Medicine, Dept. of Ophthalmology Title: Hyperlipidemia and Retinal Function Author: MK Mathews 22. June 2016: Richard D Richards Symposium. University of Maryland School of Medicine, Dept. of Ophthalmology Title: Zika for Ophthalmologists Yüklə 51,59 Kb. Dostları ilə paylaş:
|